<code id='52BDA02986'></code><style id='52BDA02986'></style>
    • <acronym id='52BDA02986'></acronym>
      <center id='52BDA02986'><center id='52BDA02986'><tfoot id='52BDA02986'></tfoot></center><abbr id='52BDA02986'><dir id='52BDA02986'><tfoot id='52BDA02986'></tfoot><noframes id='52BDA02986'>

    • <optgroup id='52BDA02986'><strike id='52BDA02986'><sup id='52BDA02986'></sup></strike><code id='52BDA02986'></code></optgroup>
        1. <b id='52BDA02986'><label id='52BDA02986'><select id='52BDA02986'><dt id='52BDA02986'><span id='52BDA02986'></span></dt></select></label></b><u id='52BDA02986'></u>
          <i id='52BDA02986'><strike id='52BDA02986'><tt id='52BDA02986'><pre id='52BDA02986'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:74124
          A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024
          Cytokinetics CEO Robert Blum spoke Thursday at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

          As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart drug, CEO Robert Blum maintains that the biotech can launch the treatment — what would be its first approved medication — on its own.

          Cytokinetics reported top-line results of its drug, aficamten, in obstructive hypertrophic cardiomyopathy, or oHCM, last December, sending its shares up on speculation the company would get acquired. Full Phase 3 results released this week further suggest the drug could be used more flexibly than a similar treatment sold by Bristol Myers Squibb, but investors have questioned whether the biotech has the resources and salesforce to compete with a large pharma company.

          advertisement

          Blum, speaking Thursday at a talk during STAT’s Breakthrough Summit West, said that if prospective buyers approach the company, he will talk to them, but “at the same time, we’re pushing forward, as we always have, with the original intention to build a commercial business. And that’s not something new. That’s not something that’s a result of a failed M&A dialogue.”

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Connecting traumatic brain injury and domestic violence
          Connecting traumatic brain injury and domestic violence

          CTbrainofapatientwithtraumaticbraininjuryshowingsubarachnoidhemorrhage.AdobeTraumaticbraininjury,lon

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Van's Gluten Free Original Waffles recalled for possible wheat allergen

          Vansglutenfreewaffles.USFDAGluten-freebreakfastfans,checkyourfreezertoensurethisnewlyrecalledfrozenw